Enteric Pathogen Panel (EPP)

**Help patients recover from gastrointestinal infections more quickly

**Gastrointestinal infections are a serious medical condition that can cause illness or death

dNTP Lab offers comprehensive testing for enteric pathogens, detecting a wide range of bacteria, viruses, and parasites responsible for gastrointestinal infections. This ensures accurate and timely results, helping patients recover more quickly.

The dNTP Enteric Pathogens Test is a rapid, easy-to-use, and cost-effective alternative to traditional stool diagnostics, providing clinical, economic, and workflow benefits. Gastrointestinal infections are a major health concern, leading to approximately 500,000 hospitalizations and 179 million outpatient visits annually in the U.S. They cause over 5,000 deaths per year and are the leading cause of death in children under 5 globally. Hospital outbreaks can result in severe illness, especially in at-risk populations, and can lead to ward closures. Diarrhea from these infections disrupts daily life and imposes a significant economic burden.

1. Comprehensive Detection:

Multiple Pathogens in One Test: Accurately identifies a broad spectrum of bacteria, viruses, and parasites responsible for gastrointestinal infections with a single stool sample.

Targeted Pathogen Identification: The panel covers common and clinically significant enteric pathogens, ensuring that the most relevant causes of gastrointestinal symptoms are detected.

2. Guided Treatment:

Tailored Therapy: By identifying the specific pathogen, the panel helps guide targeted therapy, whether it’s antibiotics, antivirals, or antiparasitic treatments, reducing the need for broad-spectrum treatments.

Avoids Unnecessary Antibiotic Use: Accurately distinguishing between bacterial, viral, and parasitic infections prevents the misuse of antibiotics, which is crucial in combating antibiotic resistance.

3. Enhanced Patient Management:

Reduces Complications: Early and accurate identification of enteric pathogens can help prevent complications such as dehydration, prolonged illness, or invasive disease.

Improves Patient Outcomes: By facilitating appropriate and timely treatment, the EPP enhances the overall management of gastrointestinal infections, leading to faster recovery and reduced hospital stays.

The FDA-approved test can detect up to 9 major gastrointestinal pathogens:

Campylobacter Group*

Salmonella spp.*

Shigella spp.*

Vibrio Group*

Yersinia enterocolitica*

Shiga Toxin 1 (stx1)*

Shiga Toxin 2 (stx2)*

Norovirus

Accreditations

Have questions or need assistance?

We’re here to help! Whether you have questions, need more information, or are ready to get started, don’t hesitate to reach out.